Silexion Therapeutics Corp SLXN

$0.23 -0.02 (-7.37%)

Valuation

Market cap
1,461,000
Revenue TTM
$0
Net income TTM
$-11,910,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
1,488,000
Avg volume
12,631,458
Day's range
$0.22 – $0.25
Shares out
5,560,000
Stochastic %K
11%
Beta
-0.29
Analysts
Sell
Price target
$5.00

Price

Company profile

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of panc...

Show more

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 2 674 3430
Website
https://silexion.com
Address
The Goldyne Savad Inst. of Gene Therapy, Hadassah Hebrew Univ Medical Ctr, Jerusalem, Israel

Latest news

Stocktwits

Monty_Roysiin Oct 7, 5:50 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $TOVX $VNRX $SLXN <
0 replies
RoundingError Oct 5, 8:10 PM
$SLXN Sitting on a small position simply due to the nature of this company's current focus on pancreatic cancer. IF they make any substantive progress, it'll likely generate interest. But it's just another bio-stock and could just die on the vine like so many seem to do. NFA, do your own research. If nothing else God bless them for trying to solve one very difficult problem...!
0 replies
Tradingistheway Oct 5, 2:08 PM
$SLXN 50k
0 replies
p983 Oct 5, 6:39 AM
$SLXN Inside, average 0.2628, we'll see!!!
0 replies
Tradingistheway Oct 5, 12:26 AM
$SLXN $5 $SDEV
0 replies
M1Tanker Oct 2, 4:21 PM
$SLXN 🔥
0 replies
BullishTrader_OT Oct 2, 3:07 PM
$SLXN lets go, let me break even and move on. Let’s stop being greedy, exit when there is a resistance folks and take profit (reminder to self)!! 🤣
0 replies
Tradingistheway Oct 2, 2:35 PM
$SLXN $9,000
0 replies